Staging and treatment response evaluation in a metastatic neuroendocrine tumor of the pancreas with G2 grading: insights from multimodality diagnostic approach by F-18-FDG and Ga-68-DOTANOC PET/CT

Endocrine. 2013 Jun;43(3):729-31. doi: 10.1007/s12020-012-9858-x. Epub 2012 Dec 18.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cisplatin / therapeutic use
  • Etoposide / therapeutic use
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Staging
  • Neuroendocrine Tumors / diagnostic imaging*
  • Neuroendocrine Tumors / drug therapy
  • Neuroendocrine Tumors / secondary
  • Pancreatic Neoplasms / diagnostic imaging*
  • Pancreatic Neoplasms / drug therapy
  • Pancreatic Neoplasms / pathology
  • Peptides, Cyclic / therapeutic use
  • Radionuclide Imaging
  • Somatostatin / analogs & derivatives
  • Somatostatin / therapeutic use
  • Treatment Outcome

Substances

  • Peptides, Cyclic
  • lanreotide
  • Fluorodeoxyglucose F18
  • Somatostatin
  • Etoposide
  • Cisplatin